CV CVS CVS Health Corporation Loading... : Bullish and Bearish Analyst Opinions

Humana is preparing for the 2027 bid with a need for larger benefit cuts than the prior year, explicitly stating the 'gap between funding and medical cost trend is larger going into this bid season than it was a year ago.' This indicates a worsening funding environment for the Medicare Advantage industry as a whole. — This signals a potential industry-wide struggle to maintain margins and could lead to more aggressive benefit cuts or premium increases across the sector, potentially impacting membership growth and valuation multiples for competitors like UNH and CVS.

Humana gained ~1 million net new MA members (20% AEP growth) with a 500 bps retention improvement; 70% of new sales were switchers from competitors, but Humana only absorbed 12% of competitor plan-exit members — less than its market share, implying rivals retained more of their exiting members or other competitors captured a larger share. — This suggests competitor plan exits (e.g., from UNH or CVS) may have driven less churn benefit to Humana than its market share would imply, potentially indicating those competitors found ways to retain more of their exiting members or other rivals captured more.